KIR3DS1

Download PDF

Recent Publications on KIR3DS1:
Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Birdshot chorioretinopathy (BCR), a chronic ocular inflammatory disease...	17th July, 2008	Ocular Inflammatory Disease Center, Jules Stein Eye Institute, David	Genes Immun. 2008 Apr;9(3):249-58. Epub 2008 Mar 13. DOI Direct Link
Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. OBJECTIVES: Natural killer (NK) cell activity is increased in individuals...	17th July, 2008	Research Institute of the McGill University Health Centre, Montreal,	AIDS. 2008 Mar 12;22(5):595-9. DOI Direct Link
Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes. We investigated killer cell immunoglobulin-like receptor (KIR) genotypes...	16th May, 2008	Department of Endocrinology and Metabolism, Kyoto Prefectural University	Tissue Antigens. 2007 Dec;70(6):506-10. DOI Direct Link
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. A flurry of recent reports on the role of activating and inhibitory forms...	14th May, 2008	Division of Experimental Medicine, Department of Medicine, San Francisco	J Virol. 2008 May;82(10):4785-92. Epub 2008 Feb 27. DOI Direct Link
Comparison of the rapidly evolving KIR locus in Parsis and natives of India. The extreme variability at the Killer cell Immunoglobulin-like Receptor...	21st March, 2008	Cancer Research Institute, Advanced Centre for Treatment, Research &	Immunogenetics. 2008 Apr;60(3-4):121-9. Epub 2008 Mar 20. DOI Direct Link
→View more research publications.

KIR3DS1 Patents:
US Patent No.	Title
7235358	Methods and compositions for diagnosing and monitoring transplant rejection
7026121	Methods and compositions for diagnosing and monitoring transplant rejection
6905827	Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases

BioPortfolio Ltd. offers e-mail and postal lists for KIR3DS1 scientists - we have details of around 5 individuals working on KIR3DS1 .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.